22-Oct-2026
147.24
-2.64 {-1.8 %}
V: 19,001,463
MRK
22-Oct-2026
Close: 147.24
-2.64 {-1.8 %}
Volume: 19,001,463
22-Sep-2026
14-Aug-2026
29-Aug-2025
28-Jun-2019
MRK
SPY
-1.8
0.9
1.3
1.3
39.9
-1.2
0.1
0.2
0.2
12.0
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
SPY tracks S&P 500 index.
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
MRK News
21-Oct-2026 - Yahoo FinanceWas There Any Sign Merck Stock Would Run? Merck (MRK) stock returned 78.7% in the twelve months to October 21, 2026, against 16.5% for the S&P 500. Over that year, ... 20-Oct-2026 - Yahoo FinanceWhat Happens To Merck Stock If Keytruda Sales Stop Growing? Shares of Merck (MRK) returned 76.2% over the past year, compared with 17.4% for the S&P 500. U.S. growth for the company's ... 20-Oct-2026 - Investor's Business DailyArcus reverses course, surging on its Merck-rivaling cancer reveal Arcus Biosciences touted its Merck-rivaling kidney cancer treatment results Tuesday, and shares rose, reversing a premarket ... 20-Oct-2026 - Yahoo FinanceMerck KGaA (XTRA:MRK) Stock Seems Hard To Call After Its 30% Run Merck KGaA has enjoyed a solid share price climb over the past year, which puts a spotlight on whether that move is matched ... 20-Oct-2026 - Insider MonkeyMerck (MRK) Has New Cancer Treatments. Can They Outgrow the Keytruda Patent Cliff? A Growing Franchise With an Expiration Date Merck & Co., Inc. (NYSE:MRK) is trying to extend its oncology leadership before ... 19-Oct-2026 - Yahoo FinanceMerck KGaA (XTRA:MRK) Makes A Rare Disease Bet With A Phase 3 Ready siRNA Deal Merck KGaA (XTRA:MRK) agreed a definitive deal to acquire Silence Therapeutics, aiming to expand its rare disease pipeline. 19-Oct-2026 - Yahoo FinanceMerck KGaA, Darmstadt, Germany to Acquire Silence Therapeutics, Strengthening Rare Disease Pipeline with Innovative siRNA Asset Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced its entry into a definitive ... 16-Oct-2026 - Yahoo FinanceAbbVie vs. Merck: Which Pharma Stock Offers Better Value? AbbVie Inc. (NYSE:ABBV) and Merck & Co., Inc. (NYSE:MRK) have something important in common that is important for investors, ... 16-Oct-2026 - Investor's Business DailyMerck stock: Watch this price, prepare to profit from this trade Merck stock has been in an uptrend. A bullish options strategy aims to profit if the drugmaker's stock keeps rising.
More MRK News
Latest MRK Trades by Congress Members
24-SEP-2026 - Maria Elvira Salazar, FL (District 27) sold some (partial sale) valued between $1,001 and $15,000.THIS TRADE WAS FILED 7-OCT-2026.
19-AUG-2026 - Maria Elvira Salazar, FL (District 27) purchased between $15,001 and $50,000.THIS TRADE WAS FILED 9-SEP-2026.
19-AUG-2026 - Maria Elvira Salazar, FL (District 27) purchased between $15,001 and $50,000.THIS TRADE WAS FILED 9-SEP-2026.
4-FEB-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 16-MAR-2026.
19-DEC-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 12-JAN-2026.
Latest MRK Trades by Congress Members
24-SEP-2026 - Maria Elvira Salazar, FL (District 27) sold some (partial sale) valued between $1,001 and $15,000.THIS TRADE WAS FILED 7-OCT-2026.
19-AUG-2026 - Maria Elvira Salazar, FL (District 27) purchased between $15,001 and $50,000.THIS TRADE WAS FILED 9-SEP-2026.
19-AUG-2026 - Maria Elvira Salazar, FL (District 27) purchased between $15,001 and $50,000.THIS TRADE WAS FILED 9-SEP-2026.
4-FEB-2026 - Josh Gottheimer, NJ (District 5) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 16-MAR-2026.
19-DEC-2025 - Gilbert Cisneros, CA (District 31) purchased between $1,001 and $15,000.THIS TRADE WAS FILED 12-JAN-2026.
More MRK Congress Trades
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved. HotCandlestick.com, LLC